The analysis of cathepsin L that mediates cellular SARS-CoV-2 infection leading to COVID-19 in head and neck squamous cell carcinoma.

Gao, Feng; Wang, Xia; Qin, Nianhong; Zhang, Mingxia; Liao, Mingfeng; Zeng, Meiqi; Lu, Desheng; Sha, Ou

Gao, Feng; Wang, Xia; Qin, Nianhong; Zhang, Mingxia; Liao, Mingfeng; Zeng, Meiqi; Lu, Desheng; Sha, Ou.

Afiliación

Gao F; School of Dentistry, Institute of Stomatological Research, Medical School, Shenzhen University, Shenzhen, China.
Wang X; Medical School, Shenzhen University, Shenzhen, China.
Qin N; Medical School, Shenzhen University, Shenzhen, China.
Zhang M; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Liao M; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
Zeng M; School of Dentistry, Institute of Stomatological Research, Medical School, Shenzhen University, Shenzhen, China.
Lu D; Medical School, Shenzhen University, Shenzhen, China.
Sha O; School of Dentistry, Institute of Stomatological Research, Medical School, Shenzhen University, Shenzhen, China.

Front Immunol ; 14: 1156038, 2023.

Article en En | MEDLINE | ID: mdl-37292206

Asunto(s)

COVID-19; Neoplasias de Cabeza y Cuello; Humanos; Carcinoma de Células Escamosas de Cabeza y Cuello; SARS-CoV-2; Catepsina L/genética; Neoplasias de Cabeza y Cuello/genética

Palabras clave

CTSL; SARS-CoV-2; cathepsin L; head and neck squamous cell carcinoma (HNSCC); immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias de Cabeza y Cuello Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google